Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2019 Oct;50(8):960-962.
doi: 10.1111/apt.15480.

Editorial: potassium-competitive acid blockers for acid-related diseases-tegoprazan, a new kid on the block

Carmelo Scarpignato  1   2   3 , Richard H Hunt  4
Affiliations
Editorial

Editorial: potassium-competitive acid blockers for acid-related diseases-tegoprazan, a new kid on the block

Carmelo Scarpignato et al. Aliment Pharmacol Ther. 2019 Oct.
No abstract available

PubMed Disclaimer

Comment on

References

REFERENCES

    1. Fatović-Ferenčić S, Banić M. No acid, no ulcer: Dragutin (Carl) Schwarz (1868-1917), the man ahead of his time. Dig Dis. 2011;29:507-510.
    1. Hunt RH. Review article: the unmet needs in delayed-release proton-pump inhibitor therapy in 2005. Aliment Pharmacol Ther. 2005;22:10-19.
    1. Hunt RH, Scarpignato C. Potent acid suppression with PPIs and P-CABs: what's new? Curr Treat Options Gastroenterol. 2018;16:570-590.
    1. Scarpignato C, Hunt RH. The potential role of potassium-competitive acid blockers in the treatment of gastroesophageal reflux disease. Curr Opin Gastroenterol. 2019;35:344-355 [Epub ahead of print].
    1. Kim H-K, Park S-H, Cheung D-Y, et al. Clinical trial: inhibitory effect of revaprazan on gastric acid secretion in healthy male subjects. J Gastroenterol Hepatol. 2010;25:1618-1625.

LinkOut - more resources